Condition: Meningioma · Sponsor: Weill Medical College of Cornell University
The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.
This description comes directly from the study's public registry record.
Jana Ivanidze, MD/PhD · 212-746-4587 · jai9018@med.cornell.edu
Alexis Watson · 646-962-2347 · alw4020@med.cornell.edu
Always discuss trial participation with your own doctor first.
| New York-Presbyterian/Weill Cornell Medical Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06377371